Michael Conger, J.D.
Before joining Inimmune, Mr. Conger served as Assistant General Counsel-Patents for GlaxoSmithKline (GSK), advising leaders of research programs for fourteen years, including a close association with the scientists who would later found Inimmune. Prior to GSK, Mr. Conger worked five years in private practice at a large, regional firm in Salt Lake City. Mr. Conger […]
Joseph Sulvoski
Joe Sulovski serves as the Vice President of Clinical Operations at Inimmune Corporation, bringing over 20 years of leadership experience in clinical research across oncology, immunology, and vaccine therapeutics. His career is distinguished by a focus on advancing innovative clinical development strategies and aligning operational priorities with organizational goals. At Inimmune, Joe plays a pivotal […]
Kendal Ryter, Ph.D.
Dr. Ryter is VP, Manufacturing and Development and Co-Founder of Inimmune. He started his postgraduate synthetic career working at Albany Molecular Research, Inc. In Albany NY. The experience highlighted his ability to adapt and come up to speed quickly on new projects and classes of drug pharmacophores. From alkaloids to opiates to complex heterocycles he […]
Helene Bazin-Lee, Ph.D.
Dr. Bazin-Lee is VP, Early Discovery and Co-Founder of Inimmune, serving as head of early discovery research programs. She has over 17 years of experience in the biotech and pharmaceutical industries including 14 years with Corixa/GlaxoSmithKline developing new synthetic immunomodulators and vaccine adjuvants, managing medicinal chemistry efforts and new adjuvant discovery projects. Dr. Bazin-Lee earned […]
Jon Ruckle, M.D.
Dr. Ruckle brings over 25 years of clinical trial experience including protocol design, product development strategy, and medical monitoring. He has served as an Investigator for over 350 clinical trials. Dr. Ruckle will oversee the global clinical development and regulatory activites for Inimmune. After receiving his medical degree from Loma Linda University and completing an […]
Mike Sullivan, CPA
Mr. Sullivan is serving as our Chief Financial Officer since December 12, 2022. Mr. Sullivan has held senior level financial positions for several publicly and privately held businesses including First Advantage Corporation, Utek Corporation, eANGLER, and HSN Direct International Limited. Most recently, he was the Chief Financial Officer for Oragenics Inc. Oragenics is a development-stage […]
Jay Evans, Ph.D.
Dr. Evans is the Chief Scientific and Strategy Officer and Cofounder of Inimmune Corp. Dr. Evans is also Director of the Center for Translational Medicine at the University of Montana and a Research Professor in the Division of Biological Sciences. He has over 20 years’ experience in the biotechnology and pharmaceutical industry including 15 years […]
David Burkhart, Ph.D.
Dr. David Burkhart is the Chief Executive Officer and a Co-Founder of Inimmune. A passionate, direct and results oriented team leader, he strives to bring out the best in people by inspiring them to realize their untapped potential. Dr. Burkhart brings nearly 20 years of experience in the biotechnology and pharmaceutical industries with proficiencies in […]
Shannon Miller, Ph.D.
Dr. Shannon Miller is the Vice President of Operations at Inimmune, where she also leads the company’s immunology R&D team. Prior to serving as VP of Operations, Dr. Miller previously served as an Investigator and Director at Inimmune and held a faculty position at the University of Montana. Dr. Miller earned her PhD in Immunology […]
